Johnson & Johnson COVID-19 Vaccine Is 66% Effective In Global Trial

Credit: CBS 3 Philly

Duration: 02:05s 29 Jan 2021 0 shares 1 views

Johnson & Johnson COVID-19 Vaccine Is 66% Effective In Global Trial

Stephanie Stahl reports.

You might like

Related news coverage

Gottlieb: Vaccines 'should be a backstop' against UK variant

Gottlieb: Vaccines 'should be a backstop' against UK variant

Reuters - Politics 31 Jan 2021

Former FDA commissioner Dr. Scott Gottlieb said inoculations "should be a backstop" against a new coronavirus variant initially..

Johnson & Jonson vaccine 66% effective

Johnson & Jonson vaccine 66% effective

FOX 4 Now Florida

30 Jan 2021

Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness

Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness

CBS 11 Dallas

30 Jan 2021

Doctor involved in Johnson & Johnson trial says single-dose vaccine is a 'game-changer'

Doctor involved in Johnson & Johnson trial says single-dose vaccine is a 'game-changer'

NewsChannel 5 Nashville

30 Jan 2021

In-depth: New data on Johnson & Johnson COVID-19 vaccine

In-depth: New data on Johnson & Johnson COVID-19 vaccine

ABC 10 News | San Diego

30 Jan 2021

Advertisement

More coverage

Health Officials Hail Johnson & Johnson's One-Dose Vaccine

Health Officials Hail Johnson & Johnson's One-Dose Vaccine

CBS 5 SF KPIX 30 Jan 2021

Although it is not quite as effective against the coronavirus as the Pfizer and Moderna vaccines, Johnson & Johnson's COVID vaccine..

Johnson & Johnson releases data on new COVID vaccine

Johnson & Johnson releases data on new COVID vaccine

FOX 47 News Michigan

30 Jan 2021

Trial Results On Johnson & Johnson COVID Vaccine Released

Trial Results On Johnson & Johnson COVID Vaccine Released

CBS 4 WCCO Minnesota

29 Jan 2021

Johnson & Johnson again calls on Tucson for vaccine trial

Johnson & Johnson again calls on Tucson for vaccine trial

KGUN, Tucson, AZ

29 Jan 2021

Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, Pfizer

Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, Pfizer

ABC Action News

29 Jan 2021